Publications
- Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Science
- Long-term treatment results of chronic myelomonocytic leukaemia in selected haematological centres2017 | Faculty of Medicine in Hradec Králové
- Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Diagnosis and treatment of chronic myelomonocytic leukemia - a view from clinical practice2016 | Publication without faculty affiliation
- Role of ruxolitinib in the treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- Diagnostics and treatment of chronic myelomonocytic leukemia in the years 2000-2013 - results from 2 hematologic centres2014 | Faculty of Medicine in Hradec Králové
- No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia2014 | Publication without faculty affiliation
- Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II2013 | First Faculty of Medicine
- Case 2-2012: a 57-year-old woman with post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for primary myelofibrosis2012 | Faculty of Medicine in Hradec Králové
- Therapy-related MDS/AML after autologous stem cell transplantation for lymphoma with BEAM as conditioning: our experience +12008 | Faculty of Medicine in Hradec Králové
Loading network view...